Influenza shots are a multibillion-dollar global business, “But how good are they?” asks an article that appeared on the 11/06/2012 issue of the New York Times’ NewYork edition entitled “Reassessing Flu Shots as the Season Draws Near”. The article refers to areport released by scientists at theUniversity of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP). The report that says that influenza vaccinations provide little protection for healthy young and middle-age adults and that they provide very little if any protection for those 65 and older, those who are most susceptible to the flu or its complications. More importantly, the report’s authors concluded that federal vaccination recommendations, which have grown in recent years, are based on inadequate evidence and poorly executed studies.
November 8, 2012